title: Renal effects of low dose prazosin in patients with congestive heart failure.
abstract: Activation of the sympathetic nervous system may contribute to the renal vasoconstriction and sodium retention seen in congestive heart failure. Previous studies in congestive heart failure patients employing large doses of prazosin that lowered systemic blood pressure have been generally disappointing. The renal haemodynamic and segmental tubular effects of low non-depressor doses of prazosin (0.25 mg and 0.50 mg) were examined in eight female patients with mild to moderate congestive heart failure. Segmental tubular function was assessed by the lithium clearance method. Compared to placebo, prazosin caused a significant increase in urinary sodium excretion (from 56 +/- 7 to 92 +/- 7 mumol.min-1, P < 0.01), paralleled by significant increases in fractional excretion of sodium and lithium. Glomerular filtration rate and effective renal plasma flow were not altered by prazosin. Prazosin pre-treatment did not alter any of the renal responses to frusemide treatment (mean dose 85 +/- 14 mg). This study demonstrates that low non-depressor doses of prazosin have a clear natriuretic effect in congestive heart failure patients, which is predominantly established by interference with tubular reabsorption.
authors.affiliation: Department of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee, U.K.
authors.forename: C C
authors.initials: CC
authors.lastname: Lang
authors.forename: A M
authors.initials: AM
authors.lastname: Choy
authors.forename: A R
authors.initials: AR
authors.lastname: Rahman
authors.forename: A D
authors.initials: AD
authors.lastname: Struthers
mesh_terms: D000368:Aged; D005260:Female; D005665:Furosemide / Q000494:pharmacology; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology* / Q000652:urine; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D008875:Middle Aged; D011224:Prazosin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D016037:Single-Blind Method; D012964:Sodium / Q000652:urine; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D005665:Furosemide; D012964:Sodium; D011224:Prazosin